Trials / Conditions / Advanced Systemic Mastocytosis

Advanced Systemic Mastocytosis

4 registered clinical trials studyying Advanced Systemic Mastocytosis.

Status	Trial	Sponsor	Phase
Terminated	Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic NCT05609942	Blueprint Medicines Corporation	Phase 1
Completed	Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM NCT04695431	Blueprint Medicines Corporation	—
Completed	(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted NCT03580655	Blueprint Medicines Corporation	Phase 2
Completed	A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies NCT02571036	Deciphera Pharmaceuticals, LLC	Phase 1